What is ArriVent BioPharma, Inc.'s AOCI?

ArriVent BioPharma, Inc. (AVBP) reported AOCI of -$270K in Q1 2026.

How has ArriVent BioPharma, Inc.'s AOCI changed year-over-year?

ArriVent BioPharma, Inc.'s AOCI decreased by 1488.2% year-over-year, from -$17K to -$270K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

ArriVent BioPharma, Inc. AVBP AOCI

AOCI at other companies

Johnson & JohnsonJNJ

-$14.83B-26.3%

Syndax PharmaceuticalsSNDX

$11K-97.9%

Nuvation BioNUVB

-$1.68M-408%

ImmunomeIMNM

$0-100%

Arcus BiosciencesRCUS

-$1M—

Erasca, Inc.ERAS

-$699K-211%

Other financials

Income statement

See full

Operating income-$46.1M+30.9%

Net income-$43.3M+32.7%

EPS (diluted)-$0.96+49.5%

Balance sheet

See full

Cash & equivalents$62.1M+24.5%

Total debt$419.0K+204%

Total equity$324.0M+60.0%

Total assets$349.3M+62.1%

Cash flow

See full

Operating cash flow-$41.9M+38.4%

Valuation

See full

Market cap$1.57B+62.1%

Enterprise value$1.51B+65.4%

Returns & leverage

See full

Return on equity-55.2%+8.0pp

Debt / equity0×0.0×

Current ratio14×-0.4×

Where this comes from

Reported directly by ArriVent BioPharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about ArriVent BioPharma, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ArriVent BioPharma, Inc.'s AOCI?: ArriVent BioPharma, Inc. (AVBP) reported AOCI of -$270K in Q1 2026.
How has ArriVent BioPharma, Inc.'s AOCI changed year-over-year?: ArriVent BioPharma, Inc.'s AOCI decreased by 1488.2% year-over-year, from -$17K to -$270K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.